These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8958953)

  • 1. Co-therapy with suboptimal doses of interleukin-12 and interferon-alpha promotes synergistic protection against herpes virus infection.
    Rogerson JA; Pole DS; Carr JA; Roberts NA; Lamont AG
    Ann N Y Acad Sci; 1996 Oct; 795():354-6. PubMed ID: 8958953
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired gamma interferon-mediated protective immunity.
    Harandi AM; Svennerholm B; Holmgren J; Eriksson K
    J Virol; 2001 Jul; 75(14):6705-9. PubMed ID: 11413339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo.
    Murphy JA; Duerst RJ; Smith TJ; Morrison LA
    J Virol; 2003 Sep; 77(17):9337-45. PubMed ID: 12915549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
    Gill N; Rosenthal KL; Ashkar AA
    J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
    Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
    J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral activities of cloned human leukocyte interferons against herpes simplex virus type 2 infections of mice.
    Fish EN; Banerjee K; Stebbing N
    J Gen Virol; 1983 Oct; 64 (Pt 10)():2317-21. PubMed ID: 6684674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of rational vaccine designs for genital herpes immunotherapy.
    Kaufmann JK; Flechtner JB
    Curr Opin Virol; 2016 Apr; 17():80-86. PubMed ID: 26896782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A heat shock protein based polyvalent vaccine targeting HSV-2: CD4(+) and CD8(+) cellular immunity and protective efficacy.
    Mo A; Musselli C; Chen H; Pappas J; Leclair K; Liu A; Chicz RM; Truneh A; Monks S; Levey DL; Srivastava PK
    Vaccine; 2011 Nov; 29(47):8530-41. PubMed ID: 21767588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of NO production in macrophages by IL-13 is counteracted by Herpes simplex virus infection through tumor necrosis factor-alpha-induced activation of NK-kappa B.
    Paludan SR; Ellermann-Eriksen S; Malmgaard L; Mogensen SC
    Eur Cytokine Netw; 2000 Jun; 11(2):275-82. PubMed ID: 10903807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of a plasmid DNA encoding IFN-alpha 1 postinfection enhances cumulative survival of herpes simplex virus type 2 vaginally infected mice.
    Härle P; Noisakran S; Carr DJ
    J Immunol; 2001 Feb; 166(3):1803-12. PubMed ID: 11160227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses elicited by the GEN-003 candidate HSV-2 therapeutic vaccine in a randomized controlled dose-ranging phase 1/2a trial.
    Flechtner JB; Long D; Larson S; Clemens V; Baccari A; Kien L; Chan J; Skoberne M; Brudner M; Hetherington S
    Vaccine; 2016 Oct; 34(44):5314-5320. PubMed ID: 27642130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of IFN-alpha/beta signaling in the prevention of genital herpes virus type 2 infection.
    Svensson A; Bellner L; Magnusson M; Eriksson K
    J Reprod Immunol; 2007 Jun; 74(1-2):114-23. PubMed ID: 17092567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells.
    Morrison LA; Zhu L; Thebeau LG
    J Virol; 2001 Feb; 75(3):1195-204. PubMed ID: 11152492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7 costimulation plays an important role in protection from herpes simplex virus type 2-mediated pathology.
    Thebeau LG; Morrison LA
    J Virol; 2002 Mar; 76(5):2563-6. PubMed ID: 11836436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Interleukin 12 Adjuvanted Herpes Simplex Virus 2 DNA Vaccine Is More Protective Than a Glycoprotein D Subunit Vaccine in a High-Dose Murine Challenge Model.
    Bagley KC; Schwartz JA; Andersen H; Eldridge JH; Xu R; Ota-Setlik A; Geltz JJ; Halford WP; Fouts TR
    Viral Immunol; 2017 Apr; 30(3):178-195. PubMed ID: 28085634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Role for Interleukin-17 in Enhancing Type 1 Helper T Cell Immunity in the Female Genital Tract following Mucosal Herpes Simplex Virus 2 Vaccination.
    Bagri P; Anipindi VC; Nguyen PV; Vitali D; Stämpfli MR; Kaushic C
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection from genital herpes disease, seroconversion and latent infection in a non-lethal murine genital infection model by immunization with an HSV-2 replication-defective mutant virus.
    Diaz FM; Knipe DM
    Virology; 2016 Jan; 488():61-7. PubMed ID: 26609935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of acute and recurrent herpes simplex virus type 2 infection with an adjuvant-free form of recombinant glycoprotein D-interleukin-2 fusion protein.
    Nakao M; Hazama M; Mayumi-Aono A; Hinuma S; Fujisawa Y
    J Infect Dis; 1994 Apr; 169(4):787-91. PubMed ID: 8133093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human leukocyte interferon-alpha in cream for the treatment of genital herpes in Asian males. A placebo-controlled, double-blind study.
    Syed TA; Cheema KM; Kahlon BM; Kahlon RC; Khayyami M; Kahlon AM; Kahlon MM
    Dermatology; 1995; 191(1):32-5. PubMed ID: 8589479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OASL1 deficiency promotes antiviral protection against genital herpes simplex virus type 2 infection by enhancing type I interferon production.
    Oh JE; Lee MS; Kim YJ; Lee HK
    Sci Rep; 2016 Jan; 6():19089. PubMed ID: 26750802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.